4.7 Article

Safety Surveillance of Mass Praziquantel and Albendazole Co-Administration in School Children from Southern Ethiopia: An Active Cohort Event Monitoring

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pharmacology & Pharmacy

Pharmacovigilance in low- and middle-income countries: A review with particular focus on Africa

Ronald Kiguba et al.

Summary: Low- and middle-income countries (LMIC) face unique challenges in establishing robust pharmacovigilance systems, including language translation, shortage of healthcare providers, high use of traditional medication, and limited awareness and investment in pharmacovigilance. Collaboration between public health programs and regulatory authorities is lacking, hindering the systematic embedding of pharmacovigilance. Furthermore, low reporting rates and poor quality reports impede signal detection analyses.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2023)

Article Chemistry, Medicinal

Safety and Tolerability of Ivermectin and Albendazole Mass Drug Administration in Lymphatic Filariasis Endemic Communities of Tanzania: A Cohort Event Monitoring Study

Adam M. Fimbo et al.

Summary: A large-scale active safety surveillance of adverse events following IA mass drug administration in Tanzania found that the incidence of experiencing MDA-associated adverse events was 4.8%, with most being mild to moderate and resolving within 72 hours. Clinical symptoms, chronic illness, and gender were identified as significant predictors of adverse events.

PHARMACEUTICALS (2022)

Article Public, Environmental & Occupational Health

Safety of Praziquantel and Albendazole Coadministration for the Control and Elimination of Schistosomiasis and Soil-Transmitted Helminths Among Children in Rwanda: An Active Surveillance Study

Joseph Kabatende et al.

Summary: This study aimed to investigate the incidence and risk factors of adverse events (AEs) following mass administration of praziquantel and albendazole. The results showed that this treatment method is safe and well-tolerated, with the majority of AEs being mild or moderate and resolving within 3 days. There were significant differences in the incidence of AEs between different genders and age groups.

DRUG SAFETY (2022)

Article Environmental Sciences

Comparative Assessment of the Pharmacovigilance Systems within the Neglected Tropical Diseases Programs in East Africa-Ethiopia, Kenya, Rwanda, and Tanzania

Abbie Barry et al.

Summary: The pharmacovigilance systems within the NTD programs in Ethiopia, Kenya, Rwanda, and Tanzania were assessed using the East African Community Harmonized Pharmacovigilance Indicators tool. Despite having strategic master plans with pharmacovigilance components, limited or no individual case safety reports were received, and there was minimal collaboration with national pharmacovigilance centers. These programs lacked a specific budget for pharmacovigilance, and although some safety monitoring elements were present, key elements such as adverse event reporting and collaboration with national centers were limited or missing.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Article Chemistry, Medicinal

Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: An Active Surveillance Study

Christabel Khaemba et al.

Summary: A large-scale prospective study in Kenya investigated adverse events following mass drug administration of diethylcarbamazine citrate and albendazole for lymphatic filariasis elimination. The study found a high cumulative incidence of AEs, with most being mild and resolving within 72 hours. Factors such as older age, concurrent medication use, and type of meal before administration were significant predictors of AEs.

PHARMACEUTICALS (2021)

Article Endocrinology & Metabolism

Sex differences in pharmacokinetics predict adverse drug reactions in women

Irving Zucker et al.

BIOLOGY OF SEX DIFFERENCES (2020)

Article Infectious Diseases

The global progress of soil-transmitted helminthiases control in 2020 and World Health Organization targets for 2030

Antonio Montresor et al.

PLOS NEGLECTED TROPICAL DISEASES (2020)

Review Infectious Diseases

Cognitive deficits and educational loss in children with schistosome infection-A systematic review and meta-analysis

Amara E. Ezeamama et al.

PLOS NEGLECTED TROPICAL DISEASES (2018)

Editorial Material Public, Environmental & Occupational Health

Safe mass drug administration for neglected tropical diseases

Dziedzom K. de Souza et al.

LANCET GLOBAL HEALTH (2018)

Review Infectious Diseases

Elimination of schistosomiasis: the tools required

Robert Bergquist et al.

INFECTIOUS DISEASES OF POVERTY (2017)

Review Biology

The contribution of mass drug administration to global health: past, present and future

Joanne P. Webster et al.

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2014)

Article Public, Environmental & Occupational Health

WHO Strategy for Collecting Safety Data in Public Health Programmes: Complementing Spontaneous Reporting Systems

Shanthi N. Pal et al.

DRUG SAFETY (2013)

Review Infectious Diseases

Preventive chemotherapy and the fight against neglected tropical diseases

Antonio Montresor et al.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2012)

Article Pharmacology & Pharmacy

Albendazole-praziquantel interaction in healthy volunteers: kinetic disposition, metabolism and enantioselectivity

Renata Monteiro Lima et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)

Article Public, Environmental & Occupational Health

Preventive chemotherapy in human helminthiasis: theoretical and operational aspects

A. -F. Gabrielli et al.

TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2011)

Article Health Care Sciences & Services

The unacknowledged impact of chronic schistosomiasis

Charles H. King et al.

CHRONIC ILLNESS (2008)

Review Medicine, General & Internal

Current concepts - Control of neglected tropical diseases

Peter J. Hotez et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Public, Environmental & Occupational Health

The WHO dose pole for the administration of praziquantel is also accurate in non-African populations

A Montresor et al.

TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2005)

Article Public, Environmental & Occupational Health

Efficacy and side effects of praziquantel against Schistosoma mansoni in a community of western Cote d'Ivoire

G Raso et al.

TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2004)

Article Public, Environmental & Occupational Health

Efficacy and side-effects of two praziquantel treatments against Schistosoma haematobium infection, among schoolchildren from Cote d'Ivoire

EK N'Goran et al.

ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY (2003)